Nobody Has a Formula for Your Portfolio Split
By Jasmine Gruia-Gray
When Agile Beats Stage-Gate: The Line Extension Case
By Jasmine Gruia-Gray
AI persona tools for life sciences, compared
By Matt Wilkinson
Stage-Gate's Eight Advances, and the Two Most Teams Use
By Jasmine Gruia-Gray
Your portfolio revenue stopped telling you the truth
By Jasmine Gruia-Gray
When to walk away: kill the business case or just table it
By Jasmine Gruia-Gray
Your audience poll came back split - read who is hiding in the tie
By Matt Wilkinson
The Fever Your Competitor Stopped Feeling: A Practical Guide to Displacing an Incumbent Vendor
By Jasmine Gruia-Gray
Stage Gates Should Ask for Evidence, Not Optimism
By Jasmine Gruia-Gray
Product Revitalisation or Exit? Run the Right Diagnostic First.
By Jasmine Gruia-Gray
Product Managers Don't Eliminate Uncertainty. They Give It a Shape.
By Jasmine Gruia-Gray
Measure What Matters: How OKRs and KPIs Fit Together at Every Stage Gate
By Jasmine Gruia-Gray
You Called It a Launch. Your Pipeline Disagrees.
By Jasmine Gruia-Gray
One Claim You Can Prove Beats Five You Cannot: The Scientist Test
By Jasmine Gruia-Gray
Sales Said You Lost on Price. Your Roadmap Believed Them.
By Jasmine Gruia-Gray